跳至主要内容
临床试验/JPRN-jRCT1051220093
JPRN-jRCT1051220093招募中Unknown

A study of treatment of cancer cachexia and for reducing side effects of standard cancer treatment with human-derived mesenchymal stem cell conditioned medium

Inami Norihito Norihito0 个研究点目标入组 20 人开始时间: 2022年9月14日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
>= 18age old 至 ot applicable(—)
性别
All

入选标准

  • 1. Patients who want to reduce side effects associated with cancer cachexia and cancer treatment.
  • 2. Patients who have been judged by the doctor to be optimally treated with conditioned medium.
  • Target patients who meet the following criteria.
  • 1. 18 years old and over
  • 2. Have normal consent ability
  • 3. Patients who can obtain their free will consent in writing
  • 4. Patients whose doctor have recognized the need for treatment

排除标准

  • Patient who meet any of the following conditions are excluded
  • 1. Have a history of or suspected of dementia
  • 2. Users of narcotics or stimulants
  • 3. Pregnant, breastfeeding
  • 4. Judged unsuitable by the doctor

研究者

发起方
Inami Norihito Norihito

相似试验